A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/26 (2006.01) A61P 1/00 (2006.01) A61P 1/12 (2006.01) A61P 25/30 (2006.01) A61P 41/00 (2006.01) A61K 38/12 (2006.01)
Patent
CA 2402733
The present invention provides an effective method for inhibiting antro- duodenal motility in healthy subjects and patients suffering from various disorders, without the side effects associated with other pharmaceutical compositions. GLP-1 slows antro-duodenal motility and may be used for the treatment or prevention of gastrointestinal disorders such as diarrhea, postoperative dumping syndrome and irritable bowel syndrome, and also premedication in endoscopic procedures.
La présente invention concerne une méthode efficace d'inhibition de la motilité antro-duodénale chez des sujets en bonne santé et des patients souffrant de divers troubles, sans occasionner d'effets secondaires associés à d'autres compositions pharmaceutiques. GLP-1 ralentit la motilité antro-duodénale et peut être utilisé dans le traitement ou la prévention de troubles gastro-intestinaux, tels que la diarrhée, le syndrome de l'anse efférente postopératoire et le syndrome du côlon irritable, et également dans la prémédication des interventions endoscopiques.
Goke Burkhard
Schirra Jorg
Amylin Pharmaceuticals Inc.
Goke Burkhard
Ridout & Maybee Llp
Schirra Jorg
LandOfFree
Effects of glucagon-like peptide-1 (7-36) on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Effects of glucagon-like peptide-1 (7-36) on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Effects of glucagon-like peptide-1 (7-36) on... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1542618